Fig. 6.
Fig. 6. Immunoprecipitation of cytokine-treated HUVEC by the β3 VNR antibody 10E2 and by the VNR complex antibody LM609. HUVEC were pretreated with IFN-γ and TNF-α and metabolically labeled with [35S] methionine and [35S]cysteine for the last 17 hours, as described. Immunoprecipitation of untreated HUVEC was performed on equivalent amounts of cell lysate with LM609 (lane 1) or the anti-β3 MoAb 10E2 (lane 2). TNF-α–treated (lane 3) and TNF-α +IFN-γ–treated (lane 4) HUVEC were immunoprecipitated with 10E2. The αv and β3 bands, which migrated at Mr = 140,000 and 110,000, respectively, are indicated by the arrows.

Immunoprecipitation of cytokine-treated HUVEC by the β3 VNR antibody 10E2 and by the VNR complex antibody LM609. HUVEC were pretreated with IFN-γ and TNF-α and metabolically labeled with [35S] methionine and [35S]cysteine for the last 17 hours, as described. Immunoprecipitation of untreated HUVEC was performed on equivalent amounts of cell lysate with LM609 (lane 1) or the anti-β3 MoAb 10E2 (lane 2). TNF-α–treated (lane 3) and TNF-α +IFN-γ–treated (lane 4) HUVEC were immunoprecipitated with 10E2. The αv and β3 bands, which migrated at Mr = 140,000 and 110,000, respectively, are indicated by the arrows.

Close Modal

or Create an Account

Close Modal
Close Modal